Unveiling a New Level of Precision: Discover The Enhanced Prolaris Test Now
Please fill out the form below and we’ll send you a genetic testing kit in just 5-7 days at no charge.
Knowing where your cancer came from could save your life, or your children’s lives.
Did you know up to 1 in 61 men with prostate cancer have a genetic mutation that may have caused their cancer? It’s true.
If you have a genetic mutation, you may be at a higher risk of developing secondary cancer or having more aggressive cancer. Genetic mutations can also be passed on. This means that your sons, daughters and siblings all have a 50% chance of having the same mutation. They could be at risk for getting the same kind of cancer or another potentially threatening form.
It can be.
Hereditary cancer occurs when a gene mutation is passed down from parent to child. People with hereditary cancer mutations in their family are more likely to have relatives with the same type or other related types of cancer.
Hereditary prostate cancer is generally more aggressive than non-hereditary types, which means that early detection, along with new treatment options, can be lifesaving. Having hereditary cancer can also mean a higher risk for developing more than one cancer and those cancers often occur at an earlier age.
If you do have hereditary prostate cancer, you want to find out early. The answers are in your genes.
If you’re newly diagnosed with prostate cancer or have already been treated for it, there are simple genetic tests that offer peace of mind and greater hope. Myriad genetic testing shows if you inherited a mutation that may have caused your cancer and whether your family members have an elevated risk. And if you’ve previously been treated for prostate cancer, genetic testing can identify your risk of developing secondary cancer in the future.
Certain genetic tests like BRACAnalysis CDx® can determine if you qualify for new FDA-approved targeted therapies – therapies that can maintain your quality of life and give you more time. By identifying if you have a germline BRCA 1/2 mutation, the test quickly and accurately establishes whether or not you’re an appropriate candidate for PARP inhibitor therapy.
Knowing your hereditary cancer status is critical when it comes to making treatment decisions and understanding your true risk.
You deserve a better answer
Families deserve a better answer
Testing is quick and easy and can be done directly in the doctor’s office by collecting a small amount of blood.
Kits are mailed directly to your house and generally arrive in 5-7 days.
Remote testing options are available. Myriad is committed to helping you understand your options.
Myriad looks at your unique genetic information using the latest in sequencing technology. Your sample is analyzed using state-of-the-art technology and reviewed by a team of genetic specialists.
Once results are available, they are sent securely to your doctor’s office. Your doctor will then help you understand your results.
Patients and their families use test results to make life-saving medical decisions. Myriad is committed to providing patients with access to accurate and affordable genetic results. We’re also here to help you understand your test results.
You have access to pre- and post-test consults with a patient educator and a board-certified genetic counselor at no additional cost.
Speak with a certified genetic counselor at Myriad if you have any questions about genetic testing. Call 888-356-0630.
To help answer any questions that you may have about your result, go to my.myriad.com/consults. You will need your accession number located at the top of your result.
97% of people have coverage for genetic testing, with 93% of all patients paying $0. For those with an out-of-pocket cost, the average is < $60.
Because patients and their families use test results to make life-saving medical decisions. Myriad is committed to providing patients with access to accurate and affordable genetic results.
Myriad is in-network with most major insurance plans including Medicare. For commercial and government-funded plans, Myriad will work with your health insurance company to obtain coverage for the test ordered by your healthcare provider.
In 1994, Myriad discovered the BRCA1 gene and subsequently introduced the first molecular diagnostic test for hereditary breast and ovarian cancer.
Hereditary cancer testing is now standard-of-care in all breast and ovarian cancer patient workups and we are committed to making genetic testing standard-of-care in prostate cancer. Myriad has since provided 7 million patients with life-changing genetic information.
Myriad is committed to expanding access to germline testing for all men with prostate cancer and providing our customers with timely and actionable results.
Better answers are here now. Schedule a no-cost and confidential appointment with a Myriad Genetics advisor to learn more about genetic testing for prostate cancer and how it could benefit you.
7 million patients tested
Committed to making testing easy and affordable
Committed to keeping your genetic privacy safe
Lifetime commitment to helping you understand your results and disease
There’s no benefit in waiting to find out if you have hereditary cancer, but there are big benefits to discovering it early. Don’t wait. Request your test kit today.
Or contact a Myriad trusted advisor at